Investigators assessed the efficacy of a machine learning tool that predicts steroid-free clinical remission in patients with ulcerative colitis receiving vedolizumab therapy.
Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.
Clinicians summarized the current research and clarified widespread misinformation on celiac disease.
Investigators conducted an open-label extension to evaluate the long-term safety and efficacy of risankizumab for the treatment of moderate to severe Crohn disease.
In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.
Study authors assessed registry data to evaluate the risk of developing childhood chronic inflammatory diseases dependent on disease status of the parents.
In addition to smoking, abdominal pain, bloating, and anemia also are strongly associated with small intestinal bacterial overgrowth.
For pediatric patients with nonbloody diarrhea, evaluating symptoms plus blood and stool markers is the optimal test strategy for predicting IBD.
Patients with inflammatory bowel disease had a similar risk for and outcomes from coronavirus disease 2019 as those in the general population.
For patients with melanoma treated with immune checkpoint inhibitors, vitamin D intake is associated with a reduced risk for ICI colitis.
